
GUALINI ELENA
Pubblicazioni
Tognola, C., Myriam Intravaia, R., Senini, E., Pezzoli, S., Riccio, A., Gualini, E., et al. (2025). Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 35(2 (February 2025)) [10.1016/j.numecd.2024.08.006]. Dettaglio
Ceruti, D., Tognola, C., Algeri, M., Shkodra, A., Politi, F., Bellantonio, V., et al. (2025). Prescriptive Appropriateness in an Outpatient Primary and Secondary Cardiovascular Prevention Service. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 32(1 (January 2025)), 99-106 [10.1007/s40292-024-00697-3]. Dettaglio
Maloberti, A., Rosa, A., Toscani, G., Caccia, A., Gualini, E., Pezzoli, S., et al. (2024). HYPERTRIGLYCERIDEMIA IN PATIENTS WITH ACUTE AND CHRONIC CORONARY SYNDROME: PREVALENCE AND THEIR ASSOCIATION WITH EXTREME CARDIOVASCULAR RISK AND LEFT VENTRICULAR FUNCTION. In ESH 2024 Abstract Book (pp.182-182). LIPPINCOTT WILLIAMS & WILKINS [10.1097/01.hjh.0001021240.82388.2e]. Dettaglio
Maloberti, A., Toscani, G., Busti, A., Tognola, C., Intravaia, R., De Censi, L., et al. (2024). EFFECT OF ANTI-PCSK9 ANTIBODIES ON ARTERY STRUCTURE AND FUNCTION: THE NIGUARDA HOSPITAL COHORT. In ESH 2024 Abstract Book (pp.299-299). LIPPINCOTT WILLIAMS & WILKINS [10.1097/01.hjh.0001022608.48617.b6]. Dettaglio
Fortuna, M., Tognola, C., Algeri, M., Shkodra, A., Intravaia, R., Pezzoli, S., et al. (2024). Hyperuricemia in Cardiac Rehabilitation Patients: Prevalence and Association with Functional Improvement and Left Ventricular Ejection Fraction. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 31(5), 461-471 [10.1007/s40292-024-00665-x]. Dettaglio